Cinnamon Treatment Upregulates Neuroprotective Proteins Parkin and DJ-1 and Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

[1]  K. Pahan,et al.  Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles , 2014, Journal of Neuroimmune Pharmacology.

[2]  K. Pahan,et al.  Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles , 2013, Journal of Neuroimmune Pharmacology.

[3]  K. Pahan,et al.  Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders , 2013, Journal of Neuroimmune Pharmacology.

[4]  K. Pahan,et al.  Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline , 2012, PloS one.

[5]  B. Bhushan,et al.  Suppression of Nuclear Factor-κB Activation and Inflammation in Microglia by Physically Modified Saline* , 2012, The Journal of Biological Chemistry.

[6]  Mei Yu,et al.  Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1- Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice , 2012, PloS one.

[7]  H. Gendelman,et al.  Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease , 2012, PloS one.

[8]  S. Ghosh,et al.  Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys , 2012, Journal of Neuroimmune Pharmacology.

[9]  K. Pahan,et al.  Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons , 2012, Journal of Neuroimmune Pharmacology.

[10]  S. Fahn.  Parkinson's disease: 10 years of progress, 1997–2007 , 2010, Movement disorders : official journal of the Movement Disorder Society.

[11]  K. Pahan,et al.  Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses1 , 2009, The Journal of Immunology.

[12]  H. Gendelman,et al.  Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease , 2009, The Journal of Neuroscience.

[13]  K. Lim,et al.  Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila , 2009, The Journal of Neuroscience.

[14]  Howard E. Gendelman,et al.  Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[15]  R. N. Saha,et al.  MAPK p38 Regulates Transcriptional Activity of NF-κB in Primary Human Astrocytes via Acetylation of p651 , 2007, The Journal of Immunology.

[16]  S. Ghosh,et al.  Involvement of Phosphatidylinositol 3-Kinase-Mediated Up-Regulation of IκBα in Anti-Inflammatory Effect of Gemfibrozil in Microglia1 , 2007, The Journal of Immunology.

[17]  K. Pahan,et al.  Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Modifies T Cells at Multiple Steps and Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis1 , 2007, The Journal of Immunology.

[18]  S. Ghosh,et al.  Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia. , 2007, Journal of immunology.

[19]  R. N. Saha,et al.  Regulation of inducible nitric oxide synthase gene in glial cells. , 2006, Antioxidants & redox signaling.

[20]  K. Pahan,et al.  Induction of Glial Fibrillary Acidic Protein Expression in Astrocytes by Nitric Oxide , 2006, The Journal of Neuroscience.

[21]  Wenbo Zhou,et al.  DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T α-Synuclein Toxicity* , 2005, Journal of Biological Chemistry.

[22]  R. N. Saha,et al.  Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. , 2005, Free radical biology & medicine.

[23]  H. Gendelman,et al.  Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. O'Brien,et al.  Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. , 2004, Molecular genetics and metabolism.

[25]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[26]  T. Ishizaki,et al.  Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans , 2004, European Journal of Clinical Pharmacology.

[27]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[28]  J. Leonard,et al.  Urea cycle disorders. , 2002, Seminars in neonatology : SN.

[29]  B. Nair,et al.  Final Report on the Safety Assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate , 2001, International journal of toxicology.

[30]  F. A. Andersen.  Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium benzoate , 2001 .

[31]  A. M. A. A. El-Mawla,et al.  Cinnamic acid is a precursor of benzoic acids in cell cultures of Hypericum androsaemum L. but not in cell cultures of Centaurium erythraea RAFN , 2001, Planta.

[32]  C. Albanese,et al.  Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism , 1998 .

[33]  C. Albanese,et al.  Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Casadevall,et al.  Reactive nitrogen intermediates in human neuropathology: an overview. , 1994, Developmental neuroscience.

[35]  L. Ignarro,et al.  Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.

[36]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[37]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[38]  J. Drapier,et al.  Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. , 1988, Journal of immunology.

[39]  B. Tóth.  Lack of tumorigenicity of sodium benzoate in mice. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[40]  R. T. Williams,et al.  The fate of benzoic acid in various species. , 1970, The Biochemical journal.